Results 101 to 110 of about 2,710 (195)

A case of accidental into-the-lens dexamethasone implant: watching or removing?

BMC Ophthalmology
Background To report a case of cataract surgery in unintentional Ozurdex (Allergan, Inc., Irvine, California, USA) injection into the lens. Case presentation A 82-years old man reporting decreased visual acuity in his right eye came to our Ophthalmology ...
Maria Ludovica Ruggeri, Alberto Quarta, Rossella D’Aloisio, Lisa Toto, Rodolfo Mastropasqua   +4 more
doaj   +1 more source

Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment

, 2017
The aim of this study was to evaluate the central retinal thickness (CRT), outer nuclear layer thickness (ONLT), photoreceptor layer thickness (PLT), photoreceptor layer integrity, and the correlation between visual acuity and PLT in eyes with branch ...
Altunel, ORHAN, Duru, Necati, Goktas, Emre, Atas, Mustafa, Goktas, Altan, Ozkose, Ayse   +5 more
core   +1 more source

Evaluación de puntos hiperreflectivos y de las capas retinianas externas en imágenes de SD-OCT de pacientes con edema macular secundario a oclusión venosa retiniana, tratados mediante el implante intravítreo de dexametasona (Ozurdex) [PDF]

, 2020
OBJETIVOS DEL ESTUDIO1. Caracterizar, en pacientes de nuestro entorno afectos de edema macular (EM) secundario a oclusión venosa retiniana (OVR), la mejor agudeza visual corregida (MAVC) y los hallazgos microestructurales retinianos observables en ...
Almenara Michelena, Cristina, Ascaso Puyuelo, Francisco Javier, Cristóbal Bescós, José Ángel   +2 more
core  

Short-term effects of intravitreal dexamethasone implant (OZURDEX (R)) on choroidal thickness in patients with naive branch retinal vein occlusion

, 2016
Purpose: The objective of this study was to evaluate subfoveal choroidal thickness (SFCT) using enhanced depth imaging optical coherence tomography (EDI-OCT) in patients with naive branch retinal vein occlusion (BRVO) before and after intravitreal ...
Altunel, ORHAN, Duru, Necati, Alabay, Bedirhan, Arifoglu, Hasan Basri, Atas, Mustafa, Baskan, Burhan   +5 more
core   +1 more source

Efficacy of dexamethasone implant in the management of chronic central serous chorioretinopathy without choroidal neovascularization

Indian Journal of Ophthalmology
Purpose: To demonstrate the treatment efficacy of intravitreal dexamethasone (DEX) implant in chronic recurrent/persistent central serous chorioretinopathy (CSC). Design: Prospective, non-randomized, open-label study.
Umesh Chandra Behera, Anand S Brar, Anup Kelgaonkar, Jyotiranjan Sahoo, Raja Narayanan, SriniVas R Sadda   +5 more
doaj   +1 more source

Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa

, 2013
To evaluate the anatomical and functional outcomes of intravitreal dexamethasone implant in patients with macular edema (ME) secondary to retinitis pigmentosa (RP).
Souied EH, Zerbib J, Tilleul J, Boulanger Scemama E, Srour M, Leveziel N, QUERQUES , GIUSEPPE   +6 more
core   +1 more source

SAFETY of INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension

, 2017
cited By 2International audiencePurpose: To analyze the incidence, risk factors, and time course of intraocular pressure elevation after intravitreal dexamethasone implant (Ozurdex).
Dot, C., Corinne Dot, Ariane Malclès, Nicolas Voirin, Voirin, Nicolas, Agard, Émilie, Bellocq, D., Dot, Corinne, Kodjikian, Laurent, Denis, P., Laurent Kodjikian, David Bellocq, Denis, Philippe, Malcles, Ariane, Malclès, A., Voirin, N., Agard, É., Vie, Anne-Laure, Anne-Laure Vié, Émilie Agard, Philippe Denis, Vié, A.-L., Bellocq, David   +22 more
core   +1 more source

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome

Clinical Ophthalmology, 2020
Maria Vadalà,1,2 Valentina Sunseri Trapani,1 Giulia Guarrasi,1 Nicasio Ventura,1 Massimo Castellucci,1 Salvatore Cillino1 1Biomedicine, Neuroscience and Advanced Diagnostic Department, University of Palermo, Palermo, Italy; 2IEMEST, Euro ...
Vadalà M, Sunseri Trapani V, Guarrasi G, Ventura N, Castellucci M, Cillino S   +5 more
doaj  

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes

Clinical Ophthalmology, 2021
Patricia Udaondo,1,2 Ana Hervas-Ontiveros,1,2 Amir Rosemblatt,3,4 Salvador Garcia-Delpech1,2 1Ophthalmology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; 2Aiken Prevencción y Cirugía Ocular, Valencia, Spain; 3Department of ...
Udaondo P, Hervas-Ontiveros A, Rosemblatt A, Garcia-Delpech S   +3 more
doaj  

Post-operative refractory cystoid macular edema in a vitrectomized eye treated with slow-release dexamethasone implant (Ozurdex)

, 2015
Introduction: The use of a slow-release dexamethasone implant (Ozurdex) for the treatment of post-operative macular edema (ME) in a vitrectomized eye has never been used before.
Droumouchtsis, V., Papakonstantinou, D., Georgalas, I., Petrou, P., Tservakis, I.   +4 more
core